CompaniesByCap
RNAC
Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare

Cartesian Therapeutics Inc. Income Statement 2014–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
Revenues
Revenue400,00038.3M26.0M110.8M85.1M16.6M6.7M903,000207,0008.1M6.0M3.0M
Gross Profit
Profitability
Operating Income-143.4M-43.9M-86.4M14.5M-4.6M-56.8M-52.5M-65.0M-63.8M-34.7M-25.3M-15.4M
EBITDA
Net Income-130.3M-77.4M-219.7M35.4M-25.7M-68.9M-55.4M-65.3M-65.3M-36.2M-25.2M-12.9M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)26M17M5M146M114M101M46M22M22M18M2M

Cartesian Therapeutics Inc. Income Statement — FAQ

Cartesian Therapeutics Inc. (RNAC) income statement over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RNAC's income statement history?

The chart and table above show Cartesian Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.